Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
plant sale
Manufacturing
Syngene to pay $37M for Emergent's Baltimore biologics plant
Syngene is paying $36.5 million for Emergent BioSolutions' Bayview plant in Baltimore, which the Indian CRDMO will use to beef up antibody production.
Fraiser Kansteiner
Mar 10, 2025 3:45pm
CDMO Joinn wraps up purchase of Lonza biologics plant in China
Jan 23, 2025 9:45am
Novavax sells Czech production plant to Novo Nordisk for $200M
Dec 4, 2024 9:27am
Evotec offloads chemical API facility for undisclosed price
Nov 7, 2024 8:04am
Nektar extends cash runway with $90M manufacturing plant sale
Nov 4, 2024 1:16pm
Catalent sells NJ production plant, HQ to Belgium's Ardena
Oct 14, 2024 9:53am
